Intuitive Surgical (NASDAQ:ISRG) Issues Quarterly Earnings Results, Beats Estimates By $0.42 EPS

21 Apr 2026, 17:06 by Scott Moore · The Cerbat Gem

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) released its quarterly earnings results on Tuesday. The medical equipment provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.08 by $0.42, FiscalAI reports. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.62 billion.

Intuitive Surgical Stock Down 3.1%

NASDAQ:ISRG traded down $14.31 during mid-day trading on Tuesday, hitting $451.29. 2,903,791 shares of the stock traded hands, compared to its average volume of 1,936,128. The stock has a market capitalization of $160.27 billion, a price-to-earnings ratio of 57.20, a PEG ratio of 3.66 and a beta of 1.68. Intuitive Surgical has a 52 week low of $427.84 and a 52 week high of $603.88. The firm’s 50 day moving average is $478.67 and its two-hundred day moving average is $515.64.

Analyst Ratings Changes

Several brokerages recently issued reports on ISRG. Barclays set a $712.00 target price on Intuitive Surgical and gave the company an “overweight” rating in a research report on Monday, January 26th. The Goldman Sachs Group lowered their price objective on Intuitive Surgical from $714.00 to $609.00 and set a “buy” rating on the stock in a research report on Wednesday, April 8th. Wall Street Zen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. TD Cowen upgraded Intuitive Surgical to a “strong-buy” rating in a research report on Tuesday, January 27th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $620.00 price target (up from $610.00) on shares of Intuitive Surgical in a report on Friday, January 23rd. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $598.36.

Get Our Latest Research Report on ISRG

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 105 shares of the stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total value of $51,864.75. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Patricia L. Wadors sold 220 shares of the stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $499.71, for a total transaction of $109,936.20. The SEC filing for this sale provides additional information. Insiders sold a total of 32,943 shares of company stock worth $17,279,568 over the last quarter. 0.60% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Intuitive Surgical

A number of hedge funds have recently modified their holdings of the business. Brighton Jones LLC boosted its stake in Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares in the last quarter. Sivia Capital Partners LLC grew its stake in Intuitive Surgical by 3.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after acquiring an additional 34 shares during the last quarter. Schnieders Capital Management LLC. boosted its stake in shares of Intuitive Surgical by 38.0% during the second quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock valued at $529,000 after acquiring an additional 268 shares during the last quarter. Caden Capital Partners LP acquired a new position in Intuitive Surgical in the 4th quarter valued at $92,000. Finally, Kemnay Advisory Services Inc. purchased a new position in shares of Intuitive Surgical during the 4th quarter worth about $79,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

Positive Sentiment: Reported Q1 results topped expectations: $2.50 EPS vs. $2.08 est. and $2.77B revenue vs. $2.62B est., showing solid margin and ROE metrics — an earnings beat that supports the company’s growth thesis. View Press Release
Positive Sentiment: Truist reaffirmed a Buy rating on ISRG (while trimming its price target), signaling continued institutional confidence in the company’s long-term positioning in robotic surgery. Truist Maintains Buy Rating on Intuitive Surgical (ISRG)
Neutral Sentiment: Pre-earnings previews and analyst model refreshes pushed estimates around the print — many firms updated numbers ahead of Q1, so part of the post-release move reflects expectation shifts rather than a pure surprise. Intuitive Surgical Q1 2026 Earnings Preview
Neutral Sentiment: Coverage pieces and long-term bull articles reiterate ISRG’s attractive multi-year track record and installed base, which supports buy-and-hold narratives despite near-term volatility. Could Buying This Healthcare Stock Today Set You Up for Life?
Negative Sentiment: Several Wall Street firms (Mizuho, BTIG, Evercore among others) trimmed price targets and estimates ahead of or after the print — these cuts increase short-term selling pressure even though ratings were often maintained. Mizuho, BTIG, and Evercore Cut Intuitive Surgical (ISRG) Price Targets
Negative Sentiment: Regulatory/market headlines (FDA alert on stapling devices and renewed scrutiny of robotic-surgery competition/adoption) add uncertainty that can pressure valuation multiple and near-term sentiment. Top Wall Street Forecasters Revamp Intuitive Surgical Expectations Ahead Of Q1 Earnings
Negative Sentiment: Commentary pieces urging reassessment of ISRG based on competitive dynamics may amplify selling from investors focused on near-term growth risk, contributing to the down move. Is It Time To Reassess Intuitive Surgical (ISRG) After Recent Robotic Surgery Headlines?

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.